Adaptive Biotechnologies Corporation (ADPT) is listed on NASDAQ in Biotech Stocks. It is $25.20, -4.69%, with a $4.0B market cap. RSI is 55.8, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 55.8 Neutral
Market Cap $4.0B
Volume 957.9K
Fundamentals — 10-Q Q2 2026
Revenue $142.4M
Net Income $-59.8M
EPS $-0.38
Gross Margin 72.7%
Operating Margin -24.6%
Net Margin -42.0%
Debt / Equity 0.0x
P/E Ratio -66.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Owen Katey Einterz | Director | Sell | 9,615 | $26.00 | $249,990 | 2026 Aug 26 |
| Hershberg Robert | Director | Sell | 30,664 | $24.40 | $748,208 | 2026 Aug 18 |
| Robins Chad M | CEO and Chairman | Sell | 600,000 | $24.80 | $14.9M | 2026 Aug 18 |
| Neupert Peter M | Director | Sell | 124,690 | $25.15 | $3.1M | 2026 Aug 17 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 3,000 | $25.00 | $75,000 | 2026 Aug 10 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 1,299 | $24.00 | $31,176 | 2026 Jul 30 |
| Robins Harlan S | Chief Scientific Officer | Sell | 492,400 | $21.89 | $10.8M | 2026 Jul 21 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 5,000 | $23.00 | $115,000 | 2026 Jul 16 |
| Lo Francis | Chief People Officer | Sell | 105,762 | $22.59 | $2.4M | 2026 Jul 15 |
| Robins Harlan S | Chief Scientific Officer | Sell | 386,240 | $22.01 | $8.5M | 2026 Jul 2 |
| Lo Francis | Chief People Officer | Sell | 95,842 | $22.51 | $2.2M | 2026 Jul 2 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 487 | $22.00 | $10,714 | 2026 Jul 1 |
| Benzeno Sharon | Chief Commercial Ofc Imm Med | Sell | 165,802 | $21.13 | $3.5M | 2026 Jun 29 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 5,000 | $20.50 | $102,500 | 2026 Jun 25 |
| Griffin Michelle Renee | Director | Sell | 52,084 | $20.18 | $1.1M | 2026 Jun 25 |
| Robins Harlan S | Chief Scientific Officer | Sell | 106,160 | $17.41 | $1.8M | 2026 Jun 16 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 5,000 | $19.00 | $95,000 | 2026 Jun 11 |
| Lo Francis | Chief People Officer | Sell | 39,741 | $17.49 | $695,070 | 2026 Jun 4 |
| Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 11,000 | $18.00 | $198,000 | 2026 Jun 4 |
| Piskel Kyle | Chief Financial Officer | Sell | 3,115 | $13.04 | $40,620 | 2026 May 18 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $8.02 | 62.4 | $3.6B |
Take ADPT further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ADPT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Adaptive Biotechnologies Corporation next reports.
Set alerts on ADPT
Get notified when Adaptive Biotechnologies Corporation hits your price targets or technical conditions are met.
Get Started Free